320 related articles for article (PubMed ID: 32111734)
21. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
22. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice.
Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B
Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235
[TBL] [Abstract][Full Text] [Related]
23. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
24. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
[TBL] [Abstract][Full Text] [Related]
25. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
26. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.
Ryu S; Kodama S; Ryu K; Schoenfeld DA; Faustman DL
J Clin Invest; 2001 Jul; 108(1):63-72. PubMed ID: 11435458
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
28. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
29. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
[TBL] [Abstract][Full Text] [Related]
30. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
31. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
32. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
[TBL] [Abstract][Full Text] [Related]
33. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
34. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
35. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
[TBL] [Abstract][Full Text] [Related]
36. Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse.
Jamison BL; DiLisio JE; Beard KS; Neef T; Bradley B; Goodman J; Gill RG; Miller SD; Baker RL; Haskins K
Diabetes; 2022 Mar; 71(3):483-496. PubMed ID: 35007324
[TBL] [Abstract][Full Text] [Related]
37. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
38. Tolerance to islet autoantigens in type 1 diabetes.
Bach JF; Chatenoud L
Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
[TBL] [Abstract][Full Text] [Related]
39. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
40. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
